Zygel, CBD Gel, to Enter Pivotal Trial in Patients With Severe Symptoms
Zynerba Pharmaceuticals announced plans to open a pivotal clinical trial next year for its cannabidiol (CBD) gel Zygel in fragile X syndrome patients with severe symptoms, a group that showed improvements in a previous Phase 2/3 study.  According…